Bioadaptives, Inc. (BDPT) Other Non-Current Liabilities (2018 - 2026)

Bioadaptives has reported Other Non-Current Liabilities for 9 years, with the latest figure at $1.6 million in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 57.72% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 57.72% YoY) and the FY2025 annual result came in at $1.7 million, up 65.09% from the prior year.
• Other Non-Current Liabilities fell to $1.6 million in Q1 2026 per BDPT's latest filing, from $1.7 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $1.7 million in Q4 2025 and troughed at $686856.0 in Q4 2022.
• A 5-year average of $1.1 million and a median of $977872.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities grew 7.71% in 2024, then jumped 65.09% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $686856.0 in 2022, then soared by 42.37% to $977872.0 in 2023, then increased by 7.71% to $1.1 million in 2024, then jumped by 65.09% to $1.7 million in 2025, then dropped by 10.06% to $1.6 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.6 million, $1.7 million, and $967406.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.